BSTE Biosite (MM)

Biosite(R) Incorporated Announces Presentation at William Blair 25th Annual Growth Stock Conference SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Biosite Incorporated (NASDAQ:BSTE) today announced that Kim Blickenstaff, Biosite's chairman and chief executive officer, and Ken Buechler, Ph.D., president and chief scientific officer, will discuss the Company's operating environment, new and potential products and the company's research and development activities at the William Blair 25th Annual Growth Stock Conference. Biosite's presentation will take place Wednesday, June 22, 2005, at 3:20 p.m. Eastern. The conference is to be held at the Four Seasons Hotel in Chicago. A link to the live audio webcast and presentation can be accessed through the Biosite website, http://www.biosite.com/. The Biosite presentation will be archived on the website for 21 days in the Investor and Media section under Events Calendar. About Biosite Incorporated Biosite Incorporated is a leading bio-medical company commercializing proteomics discoveries for the advancement of medical diagnosis. The Company's products contribute to improvements in medical care by aiding physicians in the diagnosis of critical diseases and health conditions. Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent of U.S. hospitals and in over 50 international markets. Information on Biosite can be found at http://www.biosite.com/. Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered trademarks of Biosite Incorporated. The Company's logo is a trademark of Biosite Incorporated. DATASOURCE: Biosite Incorporated CONTACT: Nadine Padilla, Vice President, Corporate and Investor Relations of Biosite Incorporated, +1-858-455-4808, ext. 3187, Web site: http://www.biosite.com/ Company News On-Call: http://www.prnewswire.com/comp/116737.html

Copyright